These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 3666078)
21. Elective tolerance to behavioral effects of neurotensin. Rinkel GJ; Hoeke EC; van Wimersma Greidanus TB Physiol Behav; 1983 Oct; 31(4):467-70. PubMed ID: 6657768 [TBL] [Abstract][Full Text] [Related]
22. Behavioral effects of neurotensin in the open field: structure-activity studies. Elliott PJ; Chan J; Parker YM; Nemeroff CB Brain Res; 1986 Sep; 381(2):259-65. PubMed ID: 3756503 [TBL] [Abstract][Full Text] [Related]
23. Behavioral effects of neurotensin: operant responding and assessment of 'anhedonia'. Rossitch E; King RA; Luttinger D; Nemeroff CB Eur J Pharmacol; 1989 Apr; 163(1):119-22. PubMed ID: 2744087 [TBL] [Abstract][Full Text] [Related]
24. Pharmacological interaction between neuropeptides and morphine or pentazocine in rat spinal cord. Stachura Z; Herman ZS Pol J Pharmacol Pharm; 1991; 43(6):459-69. PubMed ID: 1726498 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of rat pancreatic secretion by neurotensin: mechanism of action. Demol P; Laugier R; Dagorn JC; Sarles H Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):139-48. PubMed ID: 94530 [TBL] [Abstract][Full Text] [Related]
27. Cross-species comparison of the ACTH-induced behavioral syndrome. Bertolini A; Poggioli R; Vergoni AV Ann N Y Acad Sci; 1988; 525():114-29. PubMed ID: 2839061 [No Abstract] [Full Text] [Related]
28. Rotational syndrome after central injection of C-terminal 7-peptide of cholecystokinin. Mann JF; Boucher R; Schiller PW Pharmacol Biochem Behav; 1980 Jul; 13(1):125-7. PubMed ID: 7190707 [TBL] [Abstract][Full Text] [Related]
29. Microinjection of neurotensin into the CNS induces hyperdipsia in the rat. Baker JD; Hawkins MF; Baumeister AA; Nagy M Pharmacol Biochem Behav; 1989 May; 33(1):7-10. PubMed ID: 2780791 [TBL] [Abstract][Full Text] [Related]
30. [Intracerebroventricular administration of cholecystokinin inhibits the dopamine- and serotoninergic systems of the brain]. Vasar EE; Otter MIa; Riago LK Fiziol Zh SSSR Im I M Sechenova; 1982 Sep; 68(9):1218-22. PubMed ID: 7173435 [TBL] [Abstract][Full Text] [Related]
31. The effect of neurotensin on food consumption in the rat. Luttinger D; King RA; Sheppard D; Strupp J; Nemeroff CB; Prange AJ Eur J Pharmacol; 1982 Jul; 81(3):499-503. PubMed ID: 6811292 [TBL] [Abstract][Full Text] [Related]
32. Neurotensin facilitates release of substance P in the guinea-pig inferior mesenteric ganglion. Stapelfeldt WH; Szurszewski JH J Physiol; 1989 Apr; 411():325-45. PubMed ID: 2482356 [TBL] [Abstract][Full Text] [Related]
33. Behavioral effects of neurotensin. van Wimersma Greidanus TB; van Praag MC; Kalmann R; Rinkel GJ; Croiset G; Hoeke EC; van Egmond MA; Fekete M Ann N Y Acad Sci; 1982; 400():319-29. PubMed ID: 6963114 [No Abstract] [Full Text] [Related]
34. Area postrema: site where cholecystokinin acts to decrease food intake. van der Kooy D Brain Res; 1984 Mar; 295(2):345-7. PubMed ID: 6713193 [TBL] [Abstract][Full Text] [Related]
35. Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: microdialysis combined with a sequential multiple antigen radioimmunoassay. Maidment NT; Siddall BJ; Rudolph VR; Erdelyi E; Evans CJ Neuroscience; 1991; 45(1):81-93. PubMed ID: 1754070 [TBL] [Abstract][Full Text] [Related]